We are live on ! Find out more
GTC

Ghost Tree Capital Portfolio holdings

AUM $331M
1-Year Est. Return 70.11%
This Fund
S&P 500
This Quarter Est. Return
-2.22%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$415M
AUM Growth
-$201M
Cap. Flow
+$2.08M
Cap. Flow %
0.5%
Top 10 Hldgs %
36.85%
Holding
112
New
24
Increased
13
Reduced
25
Closed
42

Top Buys

Rank Stock Value
1
SHPG
Shire pic
SHPG
+$17.7M
2
MRK icon
Merck
MRK
+$13.8M
3
SGEN
Seagen Inc. Common Stock
SGEN
+$9.02M
4
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
+$8.34M
5
MNK
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
+$7.95M

Top Sells

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$10.2M
2
CLVS
Clovis Oncology, Inc.
CLVS
+$9.85M
3
CYNO
Cynosure, Inc. Class A
CYNO
+$7.64M
4
PACB icon
Pacific Biosciences
PACB
+$6.72M
5
ENTA icon
Enanta Pharmaceuticals
ENTA
+$6.65M

Sector Composition

Rank Sector Weight
1 Healthcare 77.7%
2 Miscellaneous 22.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QTNT
101
DELISTED
Quotient Limited Ordinary Shares
QTNT
– –
-1,500
Closed -$469K
GWPH
102
CALL
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-100,000
Closed -$13.3M
GHDX
103
DELISTED
Genomic Health, Inc.
GHDX
– –
-75,000
Closed -$2.17M
ALDR
104
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-16,000
Closed -$524K
HZNP
105
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-225,000
Closed -$4.08M
ELGX
106
DELISTED
Endologix Inc
ELGX
– –
-30,000
Closed -$3.84M
KTWO
107
DELISTED
K2M Group Holdings, Inc
KTWO
– –
-175,000
Closed -$3.11M
KITE
108
CALL
DELISTED
Kite Pharma, Inc.
KITE
– –
-65,000
Closed -$3.63M
PTHN
109
DELISTED
Patheon N.V.
PTHN
– –
-275,700
Closed -$4.3M
CYNO
110
DELISTED
Cynosure, Inc. Class A
CYNO
– –
-150,000
Closed -$7.64M
ARIA
111
PUT
DELISTED
Ariad Pharmaceuticals Inc
ARIA
– –
-100,000
Closed -$1.37M
CELG
112
CALL
DELISTED
Celgene Corp
CELG
– –
-75,000
Closed -$7.84M
1 2 3 4
5

Similar funds

SF
Susquehanna Foundation Bala Cynwyd, Pennsylvania $333M AUM 35.73% 1-Year Est. Return
AFS
Annapolis Financial Services Annapolis, Maryland $338M AUM 23.49% 1-Year Est. Return
SFA
Source Financial Advisors New York $338M AUM 33.62% 1-Year Est. Return
E
ETFidea Syracuse, New York $316M AUM 29.57% 1-Year Est. Return
OHCM
Oak Hill Capital Management New York $310M AUM 17.23% 1-Year Est. Return
MC
Minot Capital Broomfield, Colorado $353M AUM 25.25% 1-Year Est. Return
BRA
Biechele Royce Advisors Fishers, Indiana $303M AUM 20.64% 1-Year Est. Return
S
Syntrinsic Denver, Colorado $301M AUM 27.27% 1-Year Est. Return

Ghost Tree Capital's Q4 2016 Portfolio in Review

As of Q4 2016, Ghost Tree Capital held 112 positions worth $415M, down 33% from $617M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Ghost Tree Capital's Q4 2016 filing shows 24 new, 13 increased, 25 reduced and 42 closed positions. Its largest new stake was Shire pic: 100,000 shares worth $17M. The largest sale was Edwards Lifesciences, an estimated $10.2M.

By sector, the portfolio is most concentrated in Healthcare at 78% of assets, up from 55% a quarter earlier, followed by Miscellaneous.

  • Ghost Tree Capital's largest Q4 2016 buy was Shire pic: 100,000 shares worth $17M.
  • Ghost Tree Capital added most to AveXis, Inc. Common Stock in Q4 2016, an estimated $7.93M increase.
  • Ghost Tree Capital's biggest Q4 2016 reduction was Clovis Oncology, Inc., cutting an estimated $9.85M.
  • Ghost Tree Capital fully exited Edwards Lifesciences in Q4 2016, selling an estimated $10.2M.
  • Ghost Tree Capital's ten largest holdings make up 37% of its $415M portfolio in Q4 2016.
  • Ghost Tree Capital opened 24 new positions and closed 42 in Q4 2016.
  • Ghost Tree Capital's portfolio value fell 33% quarter-over-quarter to $415M.

Based on Ghost Tree Capital's 13F filing for Q4 2016, filed 14 Feb 2017.